168 related articles for article (PubMed ID: 31238493)
1. A Chimeric Zika Virus between Viral Strains MR766 and BeH819015 Highlights a Role for E-glycan Loop in Antibody-mediated Virus Neutralization.
Frumence E; Viranaicken W; Bos S; Alvarez-Martinez MT; Roche M; Arnaud JD; Gadea G; Desprès P
Vaccines (Basel); 2019 Jun; 7(2):. PubMed ID: 31238493
[TBL] [Abstract][Full Text] [Related]
2. A GFP Reporter MR766-Based Flow Cytometry Neutralization Test for Rapid Detection of Zika Virus-Neutralizing Antibodies in Serum Specimens.
Frumence E; Viranaicken W; Gadea G; Desprès P
Vaccines (Basel); 2019 Jul; 7(3):. PubMed ID: 31315283
[TBL] [Abstract][Full Text] [Related]
3. Immune Reactivity of a 20-mer Peptide Representing the Zika E Glycan Loop Involves the Antigenic Determinants E-152/156/158.
Frumence E; Haddad JG; Vanwalscappel B; Andries J; Decotter J; Viranaicken W; Gadea G; Desprès P
Viruses; 2020 Nov; 12(11):. PubMed ID: 33167511
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the immunogenicity of Zika glycan loop.
Henderson EA; Tam CC; Cheng LW; Ngono AE; Nguyen AV; Shresta S; McGee M; Padgett H; Grill LK; Martchenko Shilman M
Virol J; 2020 Mar; 17(1):43. PubMed ID: 32234060
[TBL] [Abstract][Full Text] [Related]
5. Dengue and Zika Virus Domain III-Flagellin Fusion and Glycan-Masking E Antigen for Prime-Boost Immunization.
Lin HH; Yang SP; Tsai MJ; Lin GC; Wu HC; Wu SC
Theranostics; 2019; 9(16):4811-4826. PubMed ID: 31367259
[TBL] [Abstract][Full Text] [Related]
6. A Measles Virus-Based Vaccine Candidate Mediates Protection against Zika Virus in an Allogeneic Mouse Pregnancy Model.
Nürnberger C; Bodmer BS; Fiedler AH; Gabriel G; Mühlebach MD
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429338
[TBL] [Abstract][Full Text] [Related]
7. The Envelope Residues E152/156/158 of Zika Virus Influence the Early Stages of Virus Infection in Human Cells.
Bos S; Viranaicken W; Frumence E; Li G; Desprès P; Zhao RY; Gadea G
Cells; 2019 Nov; 8(11):. PubMed ID: 31731738
[TBL] [Abstract][Full Text] [Related]
8. The structural proteins of epidemic and historical strains of Zika virus differ in their ability to initiate viral infection in human host cells.
Bos S; Viranaicken W; Turpin J; El-Kalamouni C; Roche M; Krejbich-Trotot P; Desprès P; Gadea G
Virology; 2018 Mar; 516():265-273. PubMed ID: 29395111
[TBL] [Abstract][Full Text] [Related]
9. Zika Virus Attenuation by Codon Pair Deoptimization Induces Sterilizing Immunity in Mouse Models.
Li P; Ke X; Wang T; Tan Z; Luo D; Miao Y; Sun J; Zhang Y; Liu Y; Hu Q; Xu F; Wang H; Zheng Z
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925661
[TBL] [Abstract][Full Text] [Related]
10. Recombinant Chimpanzee Adenovirus Vaccine AdC7-M/E Protects against Zika Virus Infection and Testis Damage.
Xu K; Song Y; Dai L; Zhang Y; Lu X; Xie Y; Zhang H; Cheng T; Wang Q; Huang Q; Bi Y; Liu WJ; Liu W; Li X; Qin C; Shi Y; Yan J; Zhou D; Gao GF
J Virol; 2018 Mar; 92(6):. PubMed ID: 29298885
[TBL] [Abstract][Full Text] [Related]
11. Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus.
Swanstrom JA; Plante JA; Plante KS; Young EF; McGowan E; Gallichotte EN; Widman DG; Heise MT; de Silva AM; Baric RS
mBio; 2016 Jul; 7(4):. PubMed ID: 27435464
[TBL] [Abstract][Full Text] [Related]
12. Immunization with phage virus-like particles displaying Zika virus potential B-cell epitopes neutralizes Zika virus infection of monkey kidney cells.
Basu R; Zhai L; Contreras A; Tumban E
Vaccine; 2018 Feb; 36(10):1256-1264. PubMed ID: 29395533
[TBL] [Abstract][Full Text] [Related]
13. Envelope Protein Glycosylation Mediates Zika Virus Pathogenesis.
Carbaugh DL; Baric RS; Lazear HM
J Virol; 2019 Jun; 93(12):. PubMed ID: 30944176
[TBL] [Abstract][Full Text] [Related]
14. The Roles of prM-E Proteins in Historical and Epidemic Zika Virus-mediated Infection and Neurocytotoxicity.
Li G; Bos S; Tsetsarkin KA; Pletnev AG; Desprès P; Gadea G; Zhao RY
Viruses; 2019 Feb; 11(2):. PubMed ID: 30769824
[TBL] [Abstract][Full Text] [Related]
15. Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus.
Garg H; Sedano M; Plata G; Punke EB; Joshi A
J Virol; 2017 Oct; 91(20):. PubMed ID: 28794019
[TBL] [Abstract][Full Text] [Related]
16. Immunization With a Novel Human Type 5 Adenovirus-Vectored Vaccine Expressing the Premembrane and Envelope Proteins of Zika Virus Provides Consistent and Sterilizing Protection in Multiple Immunocompetent and Immunocompromised Animal Models.
Guo Q; Chan JF; Poon VK; Wu S; Chan CC; Hou L; Yip CC; Ren C; Cai JP; Zhao M; Zhang AJ; Song X; Chan KH; Wang B; Kok KH; Wen Y; Yuen KY; Chen W
J Infect Dis; 2018 Jul; 218(3):365-377. PubMed ID: 29617816
[TBL] [Abstract][Full Text] [Related]
17. Probing Zika Virus Neutralization Determinants with Glycoprotein Mutants Bearing Linear Epitope Insertions.
Chambers MT; Schwarz MC; Sourisseau M; Gray ES; Evans MJ
J Virol; 2018 Sep; 92(18):. PubMed ID: 29976678
[TBL] [Abstract][Full Text] [Related]
18. Human Monoclonal Antibodies Potently Neutralize Zika Virus and Select for Escape Mutations on the Lateral Ridge of the Envelope Protein.
Bailey MJ; Broecker F; Freyn AW; Choi A; Brown JA; Fedorova N; Simon V; Lim JK; Evans MJ; García-Sastre A; Palese P; Tan GS
J Virol; 2019 Jul; 93(14):. PubMed ID: 31043537
[TBL] [Abstract][Full Text] [Related]
19. Effects of Adjuvants on the Immunogenicity and Efficacy of a Zika Virus Envelope Domain III Subunit Vaccine.
Wang X; Tai W; Zhang X; Zhou Y; Du L; Shen C
Vaccines (Basel); 2019 Oct; 7(4):. PubMed ID: 31717890
[TBL] [Abstract][Full Text] [Related]
20. ZIKV Envelope Domain-Specific Antibodies: Production, Purification and Characterization.
Akhras S; Herrlein ML; Elgner F; Holzhauser T; Hildt E
Viruses; 2019 Aug; 11(8):. PubMed ID: 31412626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
